Early Alzheimer’s Egg-Shell Protein Therapy Shows Promise in Small Human Study 7 months ago JohnIn Clinical TrialsStartups
Ultragenyx Gene Therapy Rejected by FDA Even as Takeda Scores Big in Narcolepsy Trial 9 months ago JohnIn Clinical TrialsFDA Approvals
FDA Rejects UltraGeneX’s Gene Therapy Application, Pivotal Phase III Reads Out for Takeda Narcolepsy Drug 9 months ago JohnIn Breaking NewsFDA Approvals
CSL Enters Major Partnership with VarmX to Advance Bleeding Management Drug 9 months ago JohnIn Biopharma HighlightsPartnerships
New Phase 1/2 Study Shows Promise for Oral Alzheimer’s Drug in Early Alzheimer’s Disease 9 months ago JohnIn Breaking NewsBreakthroughsInnovationTop Stories
Setrusumab Trial Update Disappoints Investors Despite Continued Clinical Progress 9 months ago JohnIn InvestmentsVenture Capital
New Regulatory Shift: NIH Requires Alternatives to Animal-Only Studies in Funded Research 9 months ago JohnIn Breaking NewsTop Stories
Strong Real-World Data Strengthens Case for Long-Acting HIV Injectables 9 months ago JohnIn Biopharma Highlights
APG777 Shows Strong Skin Clearance in Phase 2 Trial for Moderate-to-Severe Atopic Dermatitis 9 months ago JohnIn Clinical TrialsInnovationTop Stories
Bezuclastinib Delivers Strong Symptom Relief in Systemic Mastocytosis Trial 10 months ago JohnIn Clinical Trials
Rusfertide Meets Key Endpoints in Phase 3 Trial for Polycythemia Vera 10 months ago JohnIn Clinical TrialsResearch Updates
FDA and EMA Approve Phase III Trial of Masitinib Plus Docetaxel for Advanced Prostate Cancer 10 months ago JohnIn FDA ApprovalsResearch UpdatesTop Stories
FDA Gives Accelerated Approval to Lynozyfic for Hard-to-Treat Multiple Myeloma 10 months ago JohnIn FDA ApprovalsResearch UpdatesTop Stories
